A Manitoba medical marijuana producer is about to go public in a move it hopes will create hundreds more jobs.
Delta 9 Bio-Tech said Tuesday a merger with SVT Capital means it will now be listed on the Toronto Stock Exchange (TSX), likely this week.
CEO John Arbuthnot said the Winnipeg based company has more than 2,500 licensed medical marijuana users but has big plans to expand once it goes public.
Get breaking National news
For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
“A part of our go public strategy here is to raise between $25-30 million over the next six months,” Arbuthnot said.
That would allow it to take annual production from about 1,000 kilograms per year to as much as 17,000.
He said it would also allow its staff to grow from 55 to between 300-500.
- On the Brink: Ontario mom ‘one bill away from paying to go back to work’
- Liberals, NDP release costed campaign platforms as advance voting continues
- ‘Feels empowering:’ New Canadians excited to cast ballots in federal election
- ‘You, sir, are not a change’: Party leaders target Carney in final election debate
Comments